Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.19.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Operating expenses:    
Research and development $ 5,927 $ 3,572
General and administrative 2,382 1,514
Total operating expenses 8,309 5,086
Loss from operations (8,309) (5,086)
Interest income 667 139
Net loss $ (7,642) $ (4,947)
Net loss per common share, basic and diluted $ (0.40) $ (6.53)
Weighted-average shares used to compute net loss per common share, basic and diluted 19,042,524 757,399